Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:15 PM
Ignite Modification Date:
2025-12-24 @ 11:15 PM
NCT ID:
NCT05525156
Eligibility Criteria:
Inclusion Criteria:
* Consenting newly recruited male or female HIV-infected patients
* Antiretroviral drug-naïve initiating on antiretroviral drugs
* Age 18 years or older
* Willingness to stay in Dar es Salaam for at least 6 consecutive months
* Willingness to attend HIV clinics at Temeke or Mbagala Rangi Tatu or Mwananyamala hospital for at least six consecutive months
Exclusion Criteria:
* Previous intolerance or allergy to aspirin or any aspirin products
* Asthmatics
* Predisposition to bleeding (increased chance of bleeding due to being on antiplatelets and/or anticoagulants and/or having history of or active diagnosis of bleeding disorder)
* Antithrombotic therapy
* Therapy with protocol prohibited drugs
* Active or history of peptic ulcer disease
* Pregnancy
* Severe renal disease (eGFR \<30 mil/min/1.73 m2)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05525156
Study Brief:
Protocol Section:
NCT05525156